Christopherde HayduMD

Obstetrics & Gynecology • Miami, FL

Gynecologic Oncology, Hospitalist

Obstetrics & gynecology doctor Yale-New Haven Hospital

Join to view full profile

Dr. de Haydu is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. de Haydu's full profile

Already have an account?

Office
8200 SW 117th Ave
Ste 304
Miami, FL 33183
Phone+1 305-226-5651

Fax+1 305-226-2244

Education & Training

University of Miami/Jackson Health SystemFellowship, Gynecologic Oncology, 2017 - 2020
Yale-New Haven Medical CenterResidency, Obstetrics and Gynecology, 2013 - 2017
Icahn School of Medicine at Mount SinaiClass of 2013

Certifications & Licensure

FL State Medical License 2017 - 2025
American Board of Obstetrics and Gynecology Obstetrics & Gynecology

Publications & Presentations

PubMed

11 citations
Minnelide, a prodrug, inhibits cervical cancer growth by blocking HPV-induced changes in p53 and pRb.
V. Ramakrishnan, Christopher de Haydu, Peter E. Wilkinson, Urvashi Hooda, Bhuwan Giri
American Journal of Cancer Research. 2021-05-15
Has oncofertility information for male patients improved? Objective assessment of internet-based fertility preservation resources at NCI cancer centers from 2015 to 2020.
Melody A. Rasouli, Christopher de Haydu, Angela H. Liu, Janelle M. Jackman, Kajal Verma
Journal of Assisted Reproduction and Genetics. 2020-09-01
19 citations
Superior in vitro and in vivo activity of trastuzumab-emtansine (T-DM1) in comparison to trastuzumab, pertuzumab and their combination in epithelial ovarian carcinoma ...
Gulden Menderes, Elena Bonazzoli, Stefania Bellone, Gary Altwerger, Jonathan Black
Gynecologic Oncology. 2017-10-01